10x Genomics (TXG) Tops Q2 EPS by 14c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to 10x Genomics (TXG) Tops Q2 EPS by 14c, Revenues Beat

10x Genomics Reports Second Quarter 2020 Financial Results

August 11, 2020 4:06 PM EDT

PLEASANTON, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2020.

Recent Highlights

Revenue was $42.9 million for the second quarter, representing a 23% decrease over the corresponding period in 2019, with the decline resulting from widespread customer lab closures related to the COVID-19 pandemic.

Executed on our product development roadmap and launched several new products for our customers across both our Chromium and Visium platforms, including:

... More